Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

Public cautious over use of health data

UK survey finds support for wearables - if information isappropriately

- PMLiVE

AbbVie drops Galapagos JAK inhibitor to focus on ABT-494

Believes ABT-494 has potential to become best-in-class therapy

- PMLiVE

Phil Golz appointed commercial director at HealthUnlocked

Moves from ViiV Healthcare to join the socialnetwork for health

- PMLiVE

Nutraceuticals and the future of intelligent food

The convergence of food and pharmaceuticals is set to create a huge growth market

- PMLiVE

CHMP backs GSK’s asthma antibody and Novartis’ heart failure drug

Positive opinions for GSK's IL-5 antibody and Novartis' potential $5bn-a-year brand

- PMLiVE

Trevor Aukim joins emotive as head of development

Agency's recent joiners also include LizzieNayman and Ana Mootoosamy

- PMLiVE

Novartis to make 15 drugs available at $1 a month

Comes after concerns surrounding hiked drug prices and effects on public health

- PMLiVE

GSK sets its sights high for MyAsthma app

Firm wants its mobile app to be one of the best available for any disease

EISAI

Eisai takes aim at thyroid cancer myths

Educationalcampaign wants to show impact of the condition on patients

- PMLiVE

Blue Latitude retains Janssen contract

Strategic marketing consultancy will continue tosupport the firm's EMEA brand teams

- PMLiVE

Google to expand its health information role

Will add at-a-glance details on hundredsmore health conditions

National Institute for Health and Care Excellence NICE logo

NICE gives nod to Gilead’s Zydelig

First class of drug to be recommended for leukaemia

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links